GGrantIndex
← Leaderboards

Udai B Pandey

Lsu Health Sciences Center

Google Scholar ↗PubMed ↗ORCID ↗
$7,796,956
Attributed
$9,994,341
Total exposure
9
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY2013–25
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,994,341 · 9

By mechanism

R01$7,478,272 · 3
R21$2,516,069 · 6

Top collaborators

Others in their field

Top investigators on “Proteins”

Research focus

ProteinsNeuronsDrosophila GenusMutantGeneticPathogenesisToxic EffectPathway InteractionsAmyotrophic Lateral SclerosisMutationMotor NeuronsNerve DegenerationGenesIn VivoNeurodegenerative DisordersMediatingMolecularLinkHomologous GeneBiochemicalRna-Binding ProteinsFrontotemporal DementiaDefectFunctional Disorder

Grant awards (28)

Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology$759,016
R01 · FY2025 · NS
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome$539,746
R01 · FY2025 · NS · contact PI
Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology$751,016
R01 · FY2024 · NS
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome$523,554
R01 · FY2024 · NS · contact PI
Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology$766,016
R01 · FY2023 · NS
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome$539,746
R01 · FY2023 · NS · contact PI
Cellular and Molecular Mechanisms of FUS-related ALS/FTD$388,270
R01 · FY2023 · NS · contact PI
Cellular and Molecular Mechanisms of FUS-related ALS/FTD$387,493
R01 · FY2022 · NS · contact PI
Cellular and Molecular Mechanisms of FUS-related ALS/FTD$385,976
R01 · FY2021 · NS · contact PI
Cellular and Molecular Mechanisms of FUS-related ALS/FTD$383,920
R01 · FY2020 · NS · contact PI
Oligonucleotide approach to antagonize neurotoxic TDP-43 assemblies in dementia$188,892
R21 · FY2020 · AG
Targeting epigenetic modifiers of androgen receptor activity and toxicity in SBMA$397,346
R21 · FY2019 · NS · contact PI
Cellular and Molecular Mechanisms of FUS-related ALS/FTD$384,133
R01 · FY2019 · NS · contact PI
Oligonucleotide approach to antagonize neurotoxic TDP-43 assemblies in dementia$228,181
R21 · FY2019 · AG
Drosophila models for ubiquilin-associated ALS$223,488
R21 · FY2018 · NS
Nuclear export inhibition as a novel therapeutic target for C9ORF72 ALS/FTD$195,625
R21 · FY2018 · NS
Molecular mechanisms of C9orf72 and Matrin 3 interaction in ALS$195,104
R21 · FY2018 · NS · contact PI
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis$329,217
R01 · FY2017 · NS · contact PI
Nuclear export inhibition as a novel therapeutic target for C9ORF72 ALS/FTD$233,376
R21 · FY2017 · NS
Molecular mechanisms of C9orf72 and Matrin 3 interaction in ALS$232,313
R21 · FY2017 · NS · contact PI
Drosophila models for ubiquilin-associated ALS$198,244
R21 · FY2017 · NS
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis$1
R01 · FY2017 · NS · contact PI
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis$329,440
R01 · FY2016 · NS · contact PI
Mechanisms of C9orf72-associated dipeptide toxicity$192,500
R21 · FY2016 · NS
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis$345,366
R01 · FY2015 · NS · contact PI
Mechanisms of C9orf72-associated dipeptide toxicity$231,000
R21 · FY2015 · NS
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis$340,494
R01 · FY2014 · NS · contact PI
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis$324,868
R01 · FY2013 · NS · contact PI